News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
348,728 Results
Type
Article (20772)
Company Profile (147)
Press Release (327809)
Section
Business (109680)
Career Advice (1041)
Deals (19416)
Drug Delivery (97)
Drug Development (51392)
Employer Resources (102)
FDA (8760)
Job Trends (8233)
News (193313)
Policy (18068)
Tag
Academia (833)
Alliances (29283)
Alzheimer's disease (597)
Approvals (8743)
Artificial intelligence (91)
Bankruptcy (183)
Best Places to Work (5960)
Biosimilars (73)
Biotechnology (71)
Breast cancer (86)
Cancer (718)
Cardiovascular disease (71)
Career advice (862)
Cell therapy (111)
Clinical research (42491)
Collaboration (286)
Compensation (91)
COVID-19 (1137)
C-suite (69)
Data (784)
Diabetes (111)
Diagnostics (2073)
Drug pricing (97)
Earnings (39964)
Employer resources (92)
Events (49754)
Executive appointments (257)
FDA (9125)
Funding (210)
Gene therapy (101)
GLP-1 (513)
Government (1950)
Healthcare (6488)
Infectious disease (1194)
Inflammatory bowel disease (73)
Interviews (148)
IPO (7700)
Job creations (2519)
Job search strategy (776)
Layoffs (265)
Legal (4165)
Lung cancer (108)
Manufacturing (161)
Medical device (2979)
Medtech (2982)
Mergers & acquisitions (11794)
Metabolic disorders (376)
Neuroscience (798)
NextGen Class of 2024 (2621)
Non-profit (1021)
Northern California (789)
Obesity (239)
Opinion (181)
Patents (86)
People (33723)
Pharmaceutical (78)
Phase I (13256)
Phase II (17962)
Phase III (14511)
Pipeline (335)
Policy (74)
Postmarket research (1644)
Preclinical (4727)
Radiopharmaceuticals (159)
Rare diseases (171)
Real estate (3418)
Regulatory (12793)
Research institute (873)
Resumes & cover letters (155)
Southern California (727)
Startups (2093)
United States (7300)
Vaccines (229)
Weight loss (201)
Date
Today (2)
Last 7 days (146)
Last 30 days (1187)
Last 365 days (18549)
2024 (18521)
2023 (20739)
2022 (27337)
2021 (28284)
2020 (26796)
2019 (21787)
2018 (16886)
2017 (18378)
2016 (17192)
2015 (19996)
2014 (15661)
2013 (13307)
2012 (14324)
2011 (14683)
2010 (13420)
Location
Africa (436)
Asia (25333)
Australia (3305)
California (1800)
Canada (877)
China (197)
Colorado (75)
Connecticut (76)
Europe (53582)
Florida (271)
Illinois (193)
Indiana (137)
Japan (71)
Maryland (276)
Massachusetts (1499)
Minnesota (107)
New Jersey (710)
New York (507)
North Carolina (397)
Northern California (789)
Ohio (69)
Pennsylvania (436)
South America (639)
Southern California (727)
Texas (242)
Washington State (175)
348,728 Results for "flex pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Flexing on the Competition? Smaller Companies Get Higher Marks for Flexibility
Many biopharma professionals view smaller companies as having the best flexibility and remote work options, but that doesn’t mean their larger counterparts are failing in that area. Several professionals, including Apogee Therapeutics and Insmed executives, share their insights.
November 21, 2024
·
6 min read
·
Angela Gabriel
Biotech Bay
LifeSpace Labs Unveils Flex BioCulture to Revolutionize Biotech R&D Accessibility
LifeSpace Labs today announced the launch of its Flex BioCulture program.
March 12, 2024
·
2 min read
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Policy
Galvanize Receives FDA Clearance for the INUMI Flex Endoscopic Needle, Expanding its Aliya® Pulsed Electric Field (PEF) Portfolio for Soft Tissue Ablation
Galvanize announced that it received U.S. Food and Drug Administration 510 regulatory clearance for the INUMI Flex endoscopic needle for use with the Aliya® PEF System for soft tissue ablation.
May 28, 2024
·
3 min read
Press Releases
FGK Clinical Research GmbH Highlights 3.5 Years of Success with Flex Databases
October 10, 2024
·
1 min read
Deals
Two Private Equity Firms Near Potential $3B+ Deal for Mitsubishi’s Pharma Unit: Reuters
Blackstone and Bain Capital are said to be among the final bidders for the Japanese company’s Mitsubishi Tanabe Pharma, sources told Reuters Friday.
December 13, 2024
·
1 min read
·
Annalee Armstrong
Business
The Biggest Pharma Share Moves of the Year So Far
Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky.
November 27, 2024
·
9 min read
·
Annalee Armstrong
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
Ribobay Pharma boosts CRDMO offerings with Cytiva’s first FlexFactory platform for oligonucleotides
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization and a spin-off company of General Biol Co., Ltd, will provide cGMP-level oligonucleotide CRDMO services to the world using Cytiva’s first FlexFactory platform for oligo manufacturing.
May 10, 2024
·
3 min read
1 of 34,873
Next
